Publications

 

• Midgley RS, McConkey C, Kerr DJ et al. Final Results of the VICTOR Trial: A Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer. Submitted J Clin Oncol 2010

• Kerr DJ, Midgley R. Can We Treat Cancer for a Dollar a Day?  Guidelines for Low-Income Countries. Accepted for publication N Engl J Med 2010

• Kerr DJ, Midgley R. Defective Mismatch Repair in Colon Cancer: A prognostic or predictive biomarker? Accepted for Publication  J Clin Oncol 2010

• Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. (2009); Genetic prognostic and predictive markers in colorectal cancer. Nature Rev Cancer 2009 Jul; 9(7):489-99. Click <here> to read the full article.

• Kerr DJ, Dunn JA, Langman MJ, Smith JL, Midgley RS, Stanley A, Stokes JC, Julier P, Iveson C, Duvvuri R, McConkey CC; VICTOR Trial Group.(2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 2007 July 7; 26;357(4):360-9. Click <here> to read the full article.

• Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ.(2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007 Dec 15; 370(9604):2020-9. Click <here> to read the full article.

• Midgley RS, Kerr DJ (2000) Towards post-genomic investigation of colorectal cancer  Lancet 2000 Feb 26; 355 : 669-670. Click <here> to read the full article.

• Kerr DJ, Gray R, McConkey C, Barnwell J. QUASAR Colorectal Cancer Study Group. (2000) Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain.  Ann Oncol. 2000 Aug; 11(8):947-55. Click <here> to read the full article.

• QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 2000 May 6; 355(9215):1588-96. Click <here> to read the full article.

 

• A. Weaver, A.M Young, J. Rowntree, N. Townsend, S. Pearson, J. Smith, O. Gibbon, W. Cobern, M. Larsen & L. Tarassenko (2007). Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007 Oct; 18: 1887-1892. Click <here> to read the full article.

• Mark E. Larsen, Joanna Rowntree, Annie M. Young, Sarah Pearson, Justine Smith, Oliver J. Gibson, Andrew Weaver, Lionel Tarassenko (2000) Chemotherapy Side-Effect Management Using Mobile Phones. 30^th Annual International IEEE EMBS Conference, Vancouver, BC, Canada, August 20-24, 2008. Follow link to read abstract: http://www.ncbi.nlm.nih.gov/pubmed/19163877